Showing 1 - 7 results of 7 for search 'Carlo Alberto Tondini', query time: 0.04s Refine Results
  1. 1
    Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?

    Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy? by Alberto Zambelli, Carlo Alberto Tondini

    Published 2020-11-01
    Get full text
    Article
  2. 2
    A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training–Validation Trial

    A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training–Validation Trial by Alessandro Passardi, Flavia Foca, Orazio Caffo, Carlo Alberto Tondini, Alberto Zambelli, Roberto Vespignani, Giulia Bartolini, Francesco Giulio Sullo, Daniele Andreis, Marco Dianti, Claudio Eccher, Enrico Maria Piras, Stefano Forti

    Published 2022-01-01
    Get full text
    Article
  3. 3
    SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study

    SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study by Paolo Antonio Ascierto, Eliana Rulli, Anna Cecilia Bettini, Maria Grazia Vitale, Carlo Alberto Tondini, Matilde De Luca, Barbara Merelli, Mario Mandala, Sharon Nahm, Paul Lorigan, Andrea Bianchetti, Lucia Bonomi, Giorgia Negrini, Andrea Di Croce

    Published 2021-02-01
    Get full text
    Article
  4. 4
    Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study

    Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study by Francesca Corti, Jacopo Pigozzo, Eliana Rulli, Piotr Rutkowski, Carlo Alberto Tondini, Iwona Lugowska, Alice Indini, Matilde De Luca, Barbara Merelli, Anna Mariuk-Jarema, Pawel Teterycz, Pawel Rogala, Bożena Cybulska-Stopa, Alice Labianca, Lorenza Di Guardo, Michele Del Vecchio, Giovanni Randon, Mario Mandala

    Published 2020-10-01
    Get full text
    Article
  5. 5
    Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis

    Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis by Shobana Anpalakhan, Alessio Signori, Alessio Cortellini, Elena Verzoni, Raffaele Giusti, Giuseppe Aprile, Paola Ermacora, Annamaria Catino, Stefania Pipitone, Marilena Di Napoli, Vieri Scotti, Francesca Mazzoni, Pamela F. Guglielmini, Antonello Veccia, Marco Maruzzo, Giovanni Schinzari, Chiara Casadei, Francesco Grossi, Mimma Rizzo, Vincenzo Montesarchio, Francesco Verderame, Manlio Mencoboni, Fable Zustovich, Lucia Fratino, Caterina Accettura, Saverio Cinieri, Carlo Alberto Tondini, Andrea Camerini, Maria Chiara Banzi, Mariella Sorarù, Paolo Andrea Zucali, Francesca Vignani, Serena Ricciardi, Antonio Russo, Agnese Cosenza, Massimo Di Maio, Ugo De Giorgi, Sandro Pignata, Diana Giannarelli, Carmine Pinto, Sebastiano Buti, Giuseppe Fornarini, Sara Elena Rebuzzi, Pasquale Rescigno, Alfredo Addeo, Giuseppe L. Banna, Melissa Bersanelli

    Published 2023-11-01
    Get full text
    Article
  6. 6
    Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

    Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition by Dirk Schadendorf, Carola Berking, Lisa Zimmer, Serigne Lo, Caroline Robert, John Haanen, Ines Pires da Silva, Paolo Antonio Ascierto, Reinhard Dummer, Michael Manos, Joanna Mangana, Marcus O Butler, Richard D Carvajal, Georgina V Long, Alon Vaisman, Christian Posch, F Stephen Hodi, Paola Queirolo, Axel Hauschild, Christian U Blank, Maria Grazia Vitale, Carlo Alberto Tondini, Leyre Zubiri, Arielle Elkrief, Karijn P M Suijkerbuijk, Mario Mandala, Alexander M Menzies, Aljosja Rogiers, Chiara Tentori, Joseph M Grimes, Megan H Trager, Sharon Nahm, Peter Bowling, Neha Papneja, April A N Rose, Jessica S W Borgers, Severine Roy, Thiago Pimentel Muniz, Tim Cooksley, Jeremy Lupu, Samuel D Saibil, Matteo S Carlino, Michael Erdmann, Laura Pala, Ryan J Sullivan, Wilson H Miller Jr, Kerry L Reynolds, Osama E Rahma, Paul C Lorigan

    Published 2021-01-01
    Get full text
    Article
  7. 7
    Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

    Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score by Joan Brunet, Josep Tabernero, Mieke Van Hemelrijck, Salvatore Grisanti, Bruno Vincenzi, Isabel Ruiz-Camps, Juan Aguilar-Company, Daniela Ferrante, Oriol Mirallas, Amanda Jackson, Beth Russell, Ramon Salazar, Aleix Prat, Daniele Generali, Nadia Harbeck, Alberto Zambelli, Carlo Alberto Tondini, David J Pinato, Lorenza Rimassa, Armando Santoro, Neha Chopra, Tom Newsom-Davis, Gino M Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Uma Mukherjee, Mark Bower, Christopher C T Sng, Alexia Bertuzzi, Ricard Mesia, Ailsa Sita-Lumsden, Elia Seguí, Federica Biello, Pavetha Seeva, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Charlotte Moss, Rossella Bertulli, Diego Ottaviani, Raquel Liñan, Andrea Marrari, M Carmen Carmona-García, Valeria Tovazzi, Vittoria Fotia, Claudia Andrea Cruz, Nadia Saoudi-Gonzalez, Eudald Felip, Ariadna Roqué, Alvin J X Lee, David García-Illescas, Roxana Reyes, Yien Ning Sophia Wong, Lorenza Scotti, Javier Marco-Hernández, Andrea Patriarca, Lorenzo Chiudinelli, Michela Franchi, Alessandra Gennari, Nikolaos Diamantis

    Published 2021-03-01
    Get full text
    Article

Search Tools: